Journal of Biological Chemistry · 1994 · 11 citations · 48 references
Low Density LipoproteinHepatologyBiliary TractMedicineLiver PhysiologyAsialoglycoprotein ReceptorPathologyHepatotoxicityEndocrinologyExcess AsfLiver DiseaseCholangiopathiesLiverPharmacologyDrug-induced Liver InjuryRat LiverOxidative Stress
We have measured the hepatobiliary transcytosis of asialofetuin (ASF) and low density lipoprotein (LDL) in rats following treatment with 5 mg of 17 alpha-ethinylestradiol/kg of body weight for 3 days. The rate of appearance of both ligands in bile was increased 5-fold in estradiol-treated rats compared with controls. In contrast, no increase was observed in the transcytosis of dimeric IgA. The majority of the ASF recovered from the bile of estradiol-treated rats was undegraded, indicating transcytic delivery rather than lysosomal discharge. No increase in the rate of endocytosis of ASF was observed. When transcytosis of 125I-LDL was measured in the presence of excess ASF the rate decreased by approximately 70%. Moreover, sialidase treatment of LDL in vitro increased the biliary appearance of LDL 2-fold in estradiol-treated rats, suggesting that the effect of estradiol on both ligands was mediated via the asialoglycoprotein receptor. We conclude that 17 alpha-ethinylestradiol increases the transcytosis of ASF and LDL through mechanisms that alter the intracellular trafficking of the asialoglycoprotein receptor.
48
Measurement of protein using bicinchoninic acid
Pam Smith, Randall I. Krohn, Greg T. Hermanson et al. · Analytical Biochemistry · 1985 · 18.2K citations
Wei J. Chen, J L Goldstein, Mark S. Brown · Journal of Biological Chemistry · 1990 · 942 citations · Full text
Cytoplasmic Tails, Proteinlipid Interaction, Protein Function +15